These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 9657124)

  • 61. Treatment of unresectable hepatocellular carcinoma.
    Rees CR
    N Engl J Med; 1995 Sep; 333(13):877-8. PubMed ID: 7651490
    [No Abstract]   [Full Text] [Related]  

  • 62. Does the choice of treatment influence survival of patients with small hepatocellular carcinoma in compensated cirrhosis?
    Farinati F; Gianni S; Marin G; Fagiuoli S; Rinaldi M; Naccarato R
    Eur J Gastroenterol Hepatol; 2001 Oct; 13(10):1217-24. PubMed ID: 11711779
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Transarterial chemoembolization prior to liver transplantation for patients with hepatocellular carcinoma: A meta-analysis.
    Si T; Chen Y; Ma D; Gong X; Guan R; Shen B; Peng C
    J Gastroenterol Hepatol; 2017 Jul; 32(7):1286-1294. PubMed ID: 28085213
    [TBL] [Abstract][Full Text] [Related]  

  • 64. An unusual complication following transarterial chemoembolization: acute myocardial infarction.
    Lai YL; Chang WC; Kuo WH; Huang TY; Chu HC; Hsieh TY; Chang WK
    Cardiovasc Intervent Radiol; 2010 Feb; 33(1):196-200. PubMed ID: 19730938
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy of chemoembolization for hepatocellular carcinomas: experience from the Gustave Roussy Institute and the Bicêtre Hospital.
    Rougier P; Roche A; Pelletier G; Ducreux M; Pignon JP; Etienne JP
    J Surg Oncol Suppl; 1993; 3():94-6. PubMed ID: 8389181
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Efficacy of preoperative chemoembolization correlates with outcome after orthotopic liver transplantation in patients with hepatocellular carcinoma].
    Wang Y; Qu M; Shi YF; Liu YJ; Zhang CJ
    Zhonghua Gan Zang Bing Za Zhi; 2010 Oct; 18(10):785-6. PubMed ID: 21059299
    [No Abstract]   [Full Text] [Related]  

  • 67. [Changes in the lungs and pleura following chemoembolization of liver tumors with mitomycin-lipiodol].
    Lörcher U; Peters J; Kollath J
    Rofo; 1990 May; 152(5):569-73. PubMed ID: 2160691
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation.
    Mor E; Tur-Kaspa R; Sheiner P; Schwartz M
    Ann Intern Med; 1998 Oct; 129(8):643-53. PubMed ID: 9786813
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Development of non-iodized oily agent in targeting chemoembolization for hepatocellular carcinoma].
    Hamuro M; Nakamura K; Sakai Y; Kobashi S; Iuchi T; Nanata M; Nishida N; Kaminou T; Matsuoka T; Takashima S; Yamada R
    Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Sep; 58(11):581-3. PubMed ID: 9796266
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treatment of hepatocellular carcinoma in patients with cirrhosis.
    Trinchet JC; Beaugrand M
    J Hepatol; 1997 Oct; 27(4):756-65. PubMed ID: 9365054
    [No Abstract]   [Full Text] [Related]  

  • 71. Commentary: the impact of compact lipiodolisation following transarterial chemoembolisation for hepatocellular carcinoma.
    Chan SL
    Aliment Pharmacol Ther; 2012 Jul; 36(1):74-5; discussion 75. PubMed ID: 22650492
    [No Abstract]   [Full Text] [Related]  

  • 72. [Non surgical treatments of hepatocellular carcinoma].
    Roche A
    Pathol Biol (Paris); 1992 Nov; 39(9):900-1. PubMed ID: 1311442
    [No Abstract]   [Full Text] [Related]  

  • 73. [Liver chemoembolization: an update].
    Roche A
    Bull Cancer; 2009 Nov; 96(11):1111-6. PubMed ID: 19864205
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Management of hepatocellular carcinoma.
    Lai EC
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():291. PubMed ID: 7661599
    [No Abstract]   [Full Text] [Related]  

  • 75. Limitation of transcatheter arterial chemoembolization using iodized oil for small hepatocellular carcinoma. A study in resected cases.
    Kuroda C; Sakurai M; Monden M; Marukawa T; Hosoki T; Tokunaga K; Wakasa K; Okamura J; Kozuka T
    Cancer; 1991 Jan; 67(1):81-6. PubMed ID: 1845939
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hepatitis B virus reactivation after a single session of transarterial chemoembolization in patients with hepatocellular carcinoma.
    Vizzini GB; Luca A; Marino IR
    Ann Intern Med; 2003 Apr; 138(8):691-2. PubMed ID: 12693910
    [No Abstract]   [Full Text] [Related]  

  • 77. Chemoembolization for hepatocellular carcinoma.
    Zangan SM; Patel J
    Semin Roentgenol; 2011 Apr; 46(2):105-14. PubMed ID: 21338835
    [No Abstract]   [Full Text] [Related]  

  • 78. Regional strategies for managing hepatocellular carcinoma.
    Venook AP
    Oncology (Williston Park); 2000 Mar; 14(3):347-54; discussion 354, 359, 363-4. PubMed ID: 10742963
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Following a trial that stopped early: what next for adjuvant hepatic intra-arterial iodine-131 lipiodol in resectable hepatocellular carcinoma?
    Tan SB; Machin D; Cheung YB; Chung YF; Tai BC; Machin D
    J Clin Oncol; 2002 Mar; 20(6):1709. PubMed ID: 11896125
    [No Abstract]   [Full Text] [Related]  

  • 80. Biliary tumor thrombus of hepatocellular carcinoma containing lipiodol mimicking a calcified bile duct stone.
    Sasaki T; Takahara N; Kawaguchi Y; Takao H; Matsusaka K; Miyabayashi K; Yamamoto N; Hirano K; Isayama H; Kaneko J; Kokudo N; Koike K
    Endoscopy; 2012; 44 Suppl 2 UCTN():E250-1. PubMed ID: 22715018
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.